Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000233870 represents a pseudogene whose sequence is similar to part of the functional N-acetylglucosamine kinase (NAGK) gene[6]. This pseudogene does not encode a functional protein and, as such, has no confirmed role in human biology, disease, or drug targeting. The canonical N-acetylglucosamine kinase (NAGK) enzyme is a true kinase involved in amino sugar metabolism and is encoded by the separate functional NAGK gene (gene symbol: NAGK)[7][5][1]. Pseudogenes are genomic DNA sequences similar to functional genes but are usually nonfunctional due to mutations or truncations that preclude normal gene expression or protein product. There is no evidence that this pseudogene is associated with disease or therapeutic intervention[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of N-acetylglucosamine kinase (ENSG00000233870).